https://idataresearch.com/wp-content/themes/lambda-child-theme/images/footer-logo.png
https://idataresearch.com/wp-content/themes/lambda-child-theme/images/idata-white-logo.png

Cardiac Surgery

The cardiac surgery market reports include research on tissue heart valves, mechanical heart valves, annuloplasty repair devices, transcatheter heart valve repair (THVR) devices, transcatheter heart valve replacement (THVI) devices, on-pump coronary artery bypass (ONCAB) devices, off-pump coronary artery bypass (OPCAB) devices, endoscopic vessel harvesting (EVH) devices, anastomosis assist devices (AADs), transmyocardial revascularization (TMR) devices, ventricular assist devices (VADs), intra-aortic balloon pumps, artificial heart replacement devices, patent foramen ovale (PFO), atrial septal defect (ASD) devices, ventricular septal defect (VSD) devices and left atrial appendage (LAA) devices.

iData’s market research will provide insights into the following questions:

  1. How is COVID-19 affecting the global Cardiac Surgery and Heart Valve market?
  2. What is the Cardiac Surgery and Heart Valve Devices market size in the U.S.?
  3. What factors are impacting the Cardiac Surgery and Heart Valve Devices market in Japan?
  4. What is the number of total procedures in the Cardiac Surgery market? What procedure volumes are on the rise or decline within the segments in Australia?
  5. What are the major developments in the Cardiac Surgery market in the U.K.? What impact did these have on the market share in the U.K.?
  6. What is the Cardiac Surgery instruments market size of China? Which competitors hold more market share within the cardiac surgery instruments market in China?

Find your answers in the reports for: Asia Pacific, China, EuropeanU.S. or Global

Showing 1–16 of 27 results

Cardiac Surgery Market Analysis, Size, Trends | Europe | 2020-2026 | COVID19 | MedSuite

In 2020, the European cardiac surgery device market size was valued at €2.6 billion, with over 50,000 Transcatheter Aortic Valve Implantation (TAVI) procedures performed. Despite COVID19, the market size is expected to reach an insane €5.6 billion in 2026. Throughout this medical market research, we analyzed 40 cardiac surgery companies across 15 countries in Europe

more...

TAVR Market Analysis, Size, Trends | COVID19 | 2020-2026 | MedCore

In 2020, the U.S. Transcatheter Aortic Valve Replacement (TAVR) market size was valued at almost $2.4 billion, with over 75,000 TAVR procedures performed annually. In spite of COVID19, the market size is expected to increase at a cumulative growth rate of 8.7% to reach almost $5 billion in 2026. Throughout this medical market research, we

more...

Cardiac Surgery Market Analysis, Size, Trends | United States | 2020-2026 | COVID19 | MedSuite

By 2020, the U.S. cardiac surgery market size was valued at $7.2 billion, with over 91,000 transcatheter heart valve replacement (TAVR) procedures performed every year. The market size is expected to increase at a growth rate of 7.7% to reach $12.1 billion in 2026. Throughout this medical market research, we analyzed 43 cardiac surgery companies

more...

Heart Valve Market Analysis, Size, Trends | Global | 2018 – 2024 | MedCore

Industry Trends There are a few components to the heart valve market, including tissue and mechanical non-percutaneous artificial heart valves. Of these two, tissue heart valves are generally preferred over mechanical valves, due to their higher levels of biocompatibility. Tissue valves, which are also known as bioprosthetic valves, are harvested from either human donors or

more...

Cardiac Surgery Procedure Volume Analysis | Europe | 2020-2026 | MedPro

The full report suite on the European market for cardiac surgery devices includes tissue heart valves, mechanical heart valves, annuloplasty repair devices, transcatheter mitral valve repair (TMVR) devices, transcatheter aortic valve implantation (TAVI) devices, devices used to perform on and off-pump coronary artery bypass procedures, endoscopic vessel harvesting (EVH) devices, anastomosis assist devices (AADs), ventricular assist devices (VADs), intra-aortic balloon pumps (IABPs), artificial heart devices, patent foramen ovale (PFO) closure devices, atrial septal defect (ASD) closure devices and ventricular septal defect (VSD) closure devices.

more...

Transcatheter Mitral Valve Repair Device Market Analysis | Europe | 2020-2026 | MedCore

The full report suite on the European market for cardiac surgery devices includes tissue heart valves, mechanical heart valves, annuloplasty repair devices, transcatheter mitral valve repair (TMVR) devices, transcatheter aortic valve implantation (TAVI) devices, devices used to perform on and off-pump coronary artery bypass procedures, endoscopic vessel harvesting (EVH) devices, anastomosis assist devices (AADs), ventricular assist devices (VADs), intra-aortic balloon pumps (IABPs), artificial heart devices, patent foramen ovale (PFO) closure devices, atrial septal defect (ASD) closure devices and ventricular septal defect (VSD) closure devices.

more...

Cardiac Surgery Market Analysis, Size, Trends | Global | 2018-2024 | MedSuite

Industry Trends A major driver of growth in the cardiac surgery market is the aging population. As the population ages, the rate of heart failure will increase. In addition, the elderly is often not suitable for open heart surgery. The aging population also drives the growth of minimally invasive procedures, such as transcatheter heart valve

more...

Cardiac Surgery and Heart Valve Devices Product Portfolio and Pipeline | United States | 2020-2026 | MedFolio

Accurate product and industry research is a time consuming and costly affair, but a necessary part of any successful market player. Our MedFolio™ line of products can ease research burdens by compiling the latest product information across an entire market segment. We have aggregated hundreds of products by category and company, as well as comprehensive lists of press releases, regulatory announcements and future product developments. MedFolio is ideal for companies with small or limited research teams as well as those who need to supplement their research departments with new data. A MedFolio includes the following products (*Not all products are available in every MedFolio, for more information, consult the MedFolio product page of a specific report):
Executive Summary
Product Introductions
Product Portfolio (Current Products on Market)
Product Pipelines (Future Products)
Clinical Trials

more...

Cardiac Surgery and Heart Valve Devices Procedure Volume Analysis | United States | 2020-2026 | MedPro

Cardiac surgery and heart valve procedures accounts for a large array of procedures. Generally, cardiac surgery is done through open heart surgery where a surgeon opens the chest and heart. For heart valves, the surgeon could replace or repair the damaged heart valve. Another common cardiac surgery procedure would be coronary artery bypass grafting where a harvested vein is grafted onto the heart to bypass blocked arteries. This procedure can be done on-pump, where a cardioplegic solution is sued to stop the heart and the patient is put on a heart-lung machine, or off-pump, also known as beating heart surgery.

more...

Transmyocardial Revascularization Devices Market Analysis | United States | 2020-2026 | MedCore

Transmyocardial revascularization (TMR) is a surgically performed laser-based heart treatment procedure in which transmural channels are made in the heart muscle. Many scientific experts believe that these procedures encourage new vessel formation, also known as angiogenesis. TMR therapy is approved for patients suffering from chronic or severe angina. The American Heart Association (AHA) estimates that approximately 9.8 million Americans experience angina symptoms.

more...

Ventricular Assist Devices Market Analysis | United States | 2020-2026 | MedCore

Ventricular assist devices (VADs) are used for aiding a failing heart by supplementing the pumping function of the heart. VADs are often used in patients with advanced heart failure (HF). HF is a chronic disease that occurs when degeneration of the heart muscle reduces the pump power of the heart, which causes the heart to become too weak to pump blood at a level sufficient to meet the body’s demands. The condition may be caused by arterial and valve diseases or cardiomyopathy, which is disease of the heart muscle itself. Other conditions such as high blood pressure or diabetes may also lead to HF.

more...

Transcatheter Mitral Valve Repair Devices Market Analysis | United States | 2020-2026 | MedCore

The human heart contains four valves: the mitral valve, tricuspid valve, aortic valve and pulmonary valve. The mitral valve is most prone to regurgitation, which is a condition where blood is funneled back into the left atrium of the heart. Mitral regurgitation (MR) can either be caused by a congenital defect or myxomatous degeneration of the valve. Individuals with MR can suffer from atrial fibrillation, heart muscle dysfunction and even sudden death caused by cardiac arrest. In the U.S., there are just over
4 million people that may have MR, with only a minority actually diagnosed. The standard of care for MR is open surgery and/or the use of annuloplasty rings.

more...

Temporary Artificial Heart Replacement Devices Market Analysis | United States | 2020-2026 | MedCore

Artificial heart devices can be temporary or permanent mechanical devices that are designed to replace the function of a biological heart. The term “artificial heart” should not be used for describing ventricular assist devices (VADs). VADs are pumps that assist the heart but are not designed to replace it. Instead, they are used in collaboration with a patient’s heart. An artificial heart is also distinct from a cardiopulmonary bypass machine (CPB), which is an external device used for providing the functions of both the heart and lungs. CPBs are only used for a few hours at a time, most commonly during heart surgery. Artificial hearts were originally intended to be a permanent replacement for the biological human heart.

more...

Tissue Heart Valves Market Analysis | United States | 2020-2026 | MedCore

Tissue valves, which are also known as bioprosthetic valves, are harvested from either human donors or animal tissue. Human tissue valves can either be obtained from donor cadavers in allograft procedures, or from one’s own body in an autograft procedure. Allograft valves may be acquired from deceased family members or anonymous donors. Autograft valves may be obtained through a Ross procedure, whereby part of the pulmonary valve is grafted and harvested into the aortic position. Whether autograft or allograft, human donor valves involve complicated extraction and insertion procedures. Human tissue valves are in limited supply and typically do not function drastically better than xenograft valves.

more...

Patent Foramen Ovale Devices Market Analysis | United States | 2020-2026 | MedCore

A patent foramen ovale (PFO) is a defect in the septum between the two atrial chambers of the heart. Specifically, the defect is an incomplete closure of the atrial septum that results in the creation of a flap or a valve-like opening in the atrial septal wall. A PFO is distinct from a secundum atrial septal defect (ASD). A PFO is present in everyone before birth but seals shut in most people. In adults, PFO occurs when the atrial septum, which is responsible for recycling blood during womb development, does not properly occlude after birth. The condition is very common, affecting over 20% of the population. Individuals with PFO are more likely to suffer a stroke and there is evidence that migraines can be a symptom of the condition. Those who have a PFO as well as migraines often experience sensations during their migraine that include shimmering spots, blurred vision and blind spots. There are many cases where PFO patients do not need to undergo surgery and drug treatment and continual monitoring are the only measures that are necessary. However, open surgical and interventional procedures are common in patients who run the risk of having a sudden cardiac arrest.

more...

Remote Hemodynamic Monitoring Systems Market Analysis | United States | 2018-2024 | MedCore

Remote hemodynamic monitoring devices are implanted into the patient to monitor the blood pressure in the pulmonary artery. The device takes measurements from inside the body and transmits the data to a secure website for clinicians to review. The clinicians are then able to preemptively able to detect heart failure and treat them before symptoms arise.

more...